CHANTEL MOZAL: Open Payments
NPI 1730542424 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,360 in 215 payments from 19 companies in 2025. Trend: 2023 $3,728 · 2024 $3,444 · 2025 $4,360
Food & beverage: $4,129Education: $232
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $732 |
| Janssen Biotech, Inc. | 34 | $684 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 32 | $477 |
| Lilly USA, LLC | 11 | $445 |
| Galderma Laboratories, L.P. | 25 | $380 |
| UCB, Inc. | 14 | $285 |
| Novartis Pharmaceuticals Corporation | 7 | $234 |
| Incyte Corporation | 10 | $219 |
| E.R. Squibb & Sons, L.L.C. | 9 | $188 |
| Organon LLC | 7 | $169 |
Products named: TREMFYA, RINVOQ, SKYRIZI, NEMLUVIO, Bimzelx, ILUMYA, TALTZ, OPZELURA.
Industry payments across PA — which companies pay providers there.
